Stock Data
$4.31 (1.13%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
INDUSTRIALS
Industry
BUILDING PRODUCTS & EQUIPMENT
Carlisle Companies Inc, known as CSL Limited, is a global leader in biopharmaceuticals and vaccines, with a rich history dating back to 1916. Based in Melbourne, Australia, CSL operates in key markets including the US, Germany, the UK, Switzerland, and China. The company is structured into three main segments: CSL Behring, focusing on plasma products, gene therapies, and recombinants; CSL Seqirus, specializing in influenza vaccines and pandemic services; and CSL Vifor, dedicated to iron deficiency and nephrology therapies. CSL also actively licenses its intellectual property, contributing to its reputation as a pioneer in medical science.
Carlisle delivered a record quarter with EPS and revenue both topping expectations by double digits, while raising full-year guidance on pricing power that's offsetting surging material costs. The roofing and waterproofing specialist is banking on three successive price hikes through August to recover margins eroded by Middle East-driven inflation.
22 Articles
Our top personal finance-related articles today. Your wallet will thank you later.
